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Introduction: Studies on the relationship between Food and Health highlighted the importance of 
some biologically active components contained in food matrices. To date, the most studied 
biologically active polyphenols are flavonoids, some of which have shown clear estrogen-like activity, 
why are today defined as "phytoestrogens". It has been demonstrated that this components of plants, 
with molecular structures similar to steroids, could be critical modulators of human hormonal system 
and hormonal action on target tissue (1;2). Phytoestrogens have been widely studied for their potential 
therapeutic use in the prevention of cardiac disease, menopausal symptoms, osteoporosis, and some 
carcinomas since they show some of the protective effects of estrogens in absence of the side effects 
associated to estrogen administration (3). In effect many Epidemiological and experimental 
studies suggest a protective role of estrogens against colorectal cancer. Colorectal cancer is a 
multifactorial disease that results from interactions of different factors such as aging, family history 
and dietary style. Men tend to have a slightly higher incidence of colorectal cancer than women of 
similar age (American Cancer Society, 2007) and oestrogen seem to be implicated for this decreased 
risk in women. Epidemiological studies and results of Women’s Health Initiative (WHI) clinical trial, 
provide strong evidence that the colorectal cancer is hormone sensitive because the cancer risk is 
reduced in women who take HRT (Hormon Replacement Therapy) (4). Estrogen receptors alpha 
(ERα) and beta (ERβ) are the 2 known subtypes of ERs, through which estrogens exert their effects on 
various tissues. Experimental data have demonstrated that CRC express an elevated number of 
estrogen receptors (ERs), in particular estrogen receptor β. The observation that the level of ERβ 
protein is lower in malignant tumors than in normal tissue of the same organ, has fostered the 
hypothesis that ERβ may function as a tumor suppressor, protecting cells against malignant 
transformation and uncontrolled proliferation. It has been suggested that the protective effect of 
estrogens may be mediated through activation of ERβ, which has been shown to be the predominant 
subtype of ER in the gastrointestinal tract (5). 
Soy and soy foods contain a wide variety of chemical compounds, biologically active, that may 
contribute, individually or synergistically, to the health benefits of this plant; in particular polyphenols 
are considered to possess chemopreventive and therapeutic properties against cancer. Among these 
compounds there are isoflavones, the most important and abundant of which is Genistein that have 
also estrogenic properties. Phytoestrogens, present in soy based food, may act through hormonal 
mechanisms to reduce cancer risk by binding to estrogen receptors (ER) or interacting with enzymes 
involved in sex steroid biosynthesis and metabolism (6). Moreover, genistein may inhibit cancer 
progression by inducing apoptosis or inhibiting proliferation, and the mechanisms by which genistein 
exerts its anti-tumor effects has been the subject of considerable interest (7). Quercetin is a flavonoid 
present in many plant sources at levels sufficient so that it is considered to be the major flavonol 
present in the human diet. Warren (8) and others (9) have demonstrated the ability of quercetin to 
suppress the formation of early neoplastic lesions of colon cancer (aberrant crypt foci, ACF) through 
an inhibition of proliferation and apoptosis. 
Materials and Methods: We examined the activities of two of the flavonoids most common in food 
matrices, genistein and quercetin, on the colon cancer cells line HCT8-β8 engineered to overexpress 
ERβ, assuming that these compounds may play a protective action on colonic mucosa mediated by 
binding estrogen receptor β (ERβ). The aim of our study was to evaluate the in vitro effects of 
genistein (5, 25, 50, 75, 100 µM), quercetin (5, 25, 50, 75, 100 µM) and 17βE2 (10 nM) as a control, 
on a human colon cancer cell line, on cells proliferation. Lucyferase assay test was performed to study 
the interaction between genistein and quercetin and estrogen receptor β (ERβ). The presence of the 
ER-β and its levels of expression after stimulation with quercetin and genistein (50 µM) were assessed 
by the preparation of a reaction of Real-time qPCR absolute. Data were expressed as mean. Analysis 
of variance were performed. Differences were significant at p<0.05. 
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Results/Discussion: The results showed an anti-proliferative activity of genistein (Fig 1) and 
quercetin (Fig 2) at the concentration of 50, 75 and 100 µM, and 17βE2 at concentration 10 nM.  
 
 
 
 
 
 
 
 
 
 
 
 
 Fig 1. Effects of genistein on HCT8-β8  Fig 2. Effects of quercetin on HCT8-β8 
  cells proliferation     cells proliferation 
 
The polyphenols genistein and quercetin showed an inducing effect on ERβ, at concentration of 50 
µM, as demonstrated by the increase in luciferase expression compared with control. A 
superimposable effect was present when cells were stimulated with 10 nM 17βE2, used as a positive 
control. (Fig. 3). Evaluation of expression levels of ERβ in cells stimulated with genistein and 
quercetin was performed. The results of qPCR, obtained normalized to a housekeeping gene, have 
demonstrated a significant increase of ERβ levels after 6 days compared to control in cells treated with 
50 and 100 μM genistein and quercetin (Fig. 4). 
 
 
 
Fig 3. Effects of genistein and quercetin (50 µM)  Fig 4. ERβ levels, evaluated by qPCR, in on 
transactivation in HCT8-β8 cells. * p<0.05 vs          HCT8-β8 cells treated with 17βE2, untreated 
genistein cells, p<0.05 vs 17βE2-treated              and quercetin (after six days)   (*p<0.05).    
 cells.                                                                                           
 
In conclusion our study shows that genistein and quercetin are able to induce a significant inhibition of 
colon cancer cell proliferation. Inhibition of proliferation may be through a series of events, 
encompassing transactivation, and increase in the ER β expression. 
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